Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3000)
All Articles published online
|
Apr 7, 2006 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Chiang KC, Chen TW, Yeh CN, Liu FY, Lee HL, Jan YY. Advanced gastrointestinal stromal tumor patients with complete response after treatment with imatinib mesylate. World J Gastroenterol 2006; 12(13): 2060-2064 [PMID: 16610057 DOI: 10.3748/wjg.v12.i13.2060] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i13/2060.htm |
| Number | Citing Articles |
| 1 |
Safdar Ali, Sher Ali. Role of c-kit/SCF in cause and treatment of gastrointestinal stromal tumors (GIST). Gene 2007; 401(1-2): 38 doi: 10.1016/j.gene.2007.06.017
|
| 2 |
Sith Phongkitkarun, Cholada Phaisanphrukkun, Janjira Jatchavala, Ekaphop Sirachainan. Assessment of gastrointestinal stromal tumors with computed tomography following treatment with imatinib mesylate. World Journal of Gastroenterology 2008; 14(6): 892-898 doi: 10.3748/wjg.14.892
|
| 3 |
Avraham Belizon, Emre Balik, Patrick K. Horst, H. M. C. Shantha Kumara, Abu Nasar, Richard L. Whelan. Platelet-Derived Growth Factor (Subtype BB) Is Elevated in Patients with Colorectal Carcinoma. Diseases of the Colon & Rectum 2009; 52(6): 1166 doi: 10.1007/DCR.0b013e3181a0b388
|
| 4 |
Robert Y. Osamura. Roles of pathologists in molecular targeted cancer therapy. Journal of Cellular and Molecular Medicine 2009; 13(11-12): 4286 doi: 10.1111/j.1582-4934.2009.00960.x
|
| 5 |
J.Y. An, M.G. Choi, J.H. Noh, T.S. Sohn, W.K. Kang, C.K. Park, S. Kim. Gastric GIST: A single institutional retrospective experience with surgical treatment for primary disease. European Journal of Surgical Oncology (EJSO) 2007; 33(8): 1030 doi: 10.1016/j.ejso.2007.02.009
|